Accéder au contenu
Merck

Neutrophils induce macrophage anti-inflammatory reprogramming by suppressing NF-κB activation.

Cell death & disease (2018-06-06)
John A Marwick, Ross Mills, Oliver Kay, Kyriakos Michail, Jillian Stephen, Adriano G Rossi, Ian Dransfield, Nikhil Hirani
RÉSUMÉ

Apoptotic cells modulate the function of macrophages to control and resolve inflammation. Here, we show that neutrophils induce a rapid and sustained suppression of NF-κB signalling in the macrophage through a unique regulatory relationship which is independent of apoptosis. The reduction of macrophage NF-κB activation occurs through a blockade in transforming growth factor β-activated kinase 1 (TAK1) and IKKβ activation. As a consequence, NF-κB (p65) phosphorylation is reduced, its translocation to the nucleus is inhibited and NF-κB-mediated inflammatory cytokine transcription is suppressed. Gene Set Enrichment Analysis reveals that this suppression of NF-κB activation is not restricted to post-translational modifications of the canonical NF-κB pathway, but is also imprinted at the transcriptional level. Thus neutrophils exert a sustained anti-inflammatory phenotypic reprogramming of the macrophage, which is reflected by the sustained reduction in the release of pro- but not anti- inflammatory cytokines from the macrophage. Together, our findings identify a novel apoptosis-independent mechanism by which neutrophils regulate the mediator profile and reprogramming of monocytes/macrophages, representing an important nodal point for inflammatory control.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Anticorps monoclonal anti-βactine, souris, clone AC-15, purified from hybridoma cell culture
Sigma-Aldrich
Monoclonal Anti-GAPDH−Peroxidase antibody produced in mouse, clone GAPDH-71.1, purified immunoglobulin, buffered aqueous solution
Sigma-Aldrich
Anti-NFκB p65 Antibody, phospho-specific (Ser276), serum, Chemicon®